401 related articles for article (PubMed ID: 15237024)
1. A danazol-loaded intrauterine device decreases dysmenorrhea, pelvic pain, and dyspareunia associated with endometriosis.
Cobellis L; Razzi S; Fava A; Severi FM; Igarashi M; Petraglia F
Fertil Steril; 2004 Jul; 82(1):239-40. PubMed ID: 15237024
[TBL] [Abstract][Full Text] [Related]
2. Pain of endometriosis: effects of nafarelin and danazol therapy.
Adamson GD; Kwei L; Edgren RA
Int J Fertil Menopausal Stud; 1994; 39(4):215-7. PubMed ID: 7951404
[TBL] [Abstract][Full Text] [Related]
3. Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial.
Tanmahasamut P; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Indhavivadhana S; Leerasiri P
Obstet Gynecol; 2012 Mar; 119(3):519-26. PubMed ID: 22314873
[TBL] [Abstract][Full Text] [Related]
4. Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis.
Ferrero S; Camerini G; Seracchioli R; Ragni N; Venturini PL; Remorgida V
Hum Reprod; 2009 Dec; 24(12):3033-41. PubMed ID: 19726448
[TBL] [Abstract][Full Text] [Related]
5. [Levonorgestrel-releasing intrauterine system for treatment of dysmenorrhea associated with adenomyosis].
Sheng J; Lu D; Zhang JP; Cui GF
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):467-70. PubMed ID: 17083813
[TBL] [Abstract][Full Text] [Related]
6. Direct effect of danazol on endometrial hyperplasia in adenomyotic women: treatment with danazol containing intrauterine device.
Tamaoka Y; Orikasa H; Sumi Y; Sakakura K; Kamei K; Nagatani M; Ezawa S
Hum Cell; 2000 Sep; 13(3):127-33. PubMed ID: 11197774
[TBL] [Abstract][Full Text] [Related]
7. Clinical pitfalls of pain recurrence in endometriosis arising in the posterior vaginal fornix.
Tachibana M; Murakami T; Utsunomiya H; Terada Y; Yaegashi N; Okamura K
J Obstet Gynaecol Res; 2007 Apr; 33(2):207-10. PubMed ID: 17441898
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the efficacy of a danazol-loaded intrauterine contraceptive device on adenomyosis in an ICR mouse model.
Zhang X; Yuan H; Deng L; Hu F; Ma J; Lin J
Hum Reprod; 2008 Sep; 23(9):2024-30. PubMed ID: 18552364
[TBL] [Abstract][Full Text] [Related]
9. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea.
Bahamondes L; Petta CA; Fernandes A; Monteiro I
Contraception; 2007 Jun; 75(6 Suppl):S134-9. PubMed ID: 17531605
[TBL] [Abstract][Full Text] [Related]
10. Pain symptoms associated with endometriosis.
Fedele L; Bianchi S; Bocciolone L; Di Nola G; Parazzini F
Obstet Gynecol; 1992 May; 79(5 ( Pt 1)):767-9. PubMed ID: 1565363
[TBL] [Abstract][Full Text] [Related]
11. Vaginal danazol for women with rectovaginal endometriosis and pain symptoms persisting after insertion of a levonorgestrel-releasing intrauterine device.
Ferrero S; Tramalloni D; Venturini PL; Remorgida V
Int J Gynaecol Obstet; 2011 May; 113(2):116-9. PubMed ID: 21333989
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis.
Razzi S; Luisi S; Calonaci F; Altomare A; Bocchi C; Petraglia F
Fertil Steril; 2007 Oct; 88(4):789-94. PubMed ID: 17544421
[TBL] [Abstract][Full Text] [Related]
13. [Local administration of danazol on pelvic endometriosis and uterine adenomyosis].
Igarashi M; Fukuda M; Ando A; Miyasaka M; Taguchi H; Yoshida M; Abe Y
Nihon Rinsho; 2001 Jan; 59 Suppl 1():153-6. PubMed ID: 11235155
[No Abstract] [Full Text] [Related]
14. Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis.
Cho S; Nam A; Kim H; Chay D; Park K; Cho DJ; Park Y; Lee B
Am J Obstet Gynecol; 2008 Apr; 198(4):373.e1-7. PubMed ID: 18177833
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of leuprorelin acetate and danazol treatments on serum CA-125 levels in women with endometriosis.
Matalliotakis IM; Arici A; Goumenou AG; Katassos T; Karkavitsas N; Koumantakis EE
Int J Fertil Womens Med; 2004; 49(2):75-8. PubMed ID: 15188832
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between pain symptoms and clinico-pathological features of pelvic endometriosis].
Leng JH; Lang JH; Dai Y; Li HJ; Li XY
Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):165-8. PubMed ID: 17537300
[TBL] [Abstract][Full Text] [Related]
17. [Guidelines for the management of painful endometriosis].
Roman H
J Gynecol Obstet Biol Reprod (Paris); 2007 Apr; 36(2):141-50. PubMed ID: 17276016
[TBL] [Abstract][Full Text] [Related]
18. [Painful symptoms of pelvic endometriosis].
Zhou Y; Wu B
Zhonghua Fu Chan Ke Za Zhi; 1995 Jan; 30(1):30-3. PubMed ID: 7750405
[TBL] [Abstract][Full Text] [Related]
19. The role of the levonorgestrel-releasing intrauterine device in the management of symptomatic endometriosis.
Vercellini P; Viganò P; Somigliana E
Curr Opin Obstet Gynecol; 2005 Aug; 17(4):359-65. PubMed ID: 15976541
[TBL] [Abstract][Full Text] [Related]
20. Maintenance therapy involving a tapering dose of danazol or mid/low doses of oral contraceptive after gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
Kitawaki J; Ishihara H; Kiyomizu M; Honjo H
Fertil Steril; 2008 Jun; 89(6):1831-5. PubMed ID: 17761178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
